NDC 65841-706

Gabapentin

Gabapentin

Gabapentin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Gabapentin.

Product ID65841-706_62f7b0d7-c088-42f8-8e1f-7dea5f736fb9
NDC65841-706
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2012-10-16
Marketing CategoryANDA / ANDA
Application NumberANDA078926
Labeler NameZydus Lifesciences Limited
Substance NameGABAPENTIN
Active Ingredient Strength800 mg/1
Pharm ClassesAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65841-706-01

100 TABLET, FILM COATED in 1 BOTTLE (65841-706-01)
Marketing Start Date2012-10-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65841-706-30 [65841070630]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA078926
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-10-16
Marketing End Date2019-12-03

NDC 65841-706-10 [65841070610]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA078926
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-10-16

NDC 65841-706-01 [65841070601]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA078926
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-10-16

NDC 65841-706-05 [65841070605]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA078926
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-10-16

NDC 65841-706-77 [65841070677]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA078926
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-10-16

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN800 mg/1

OpenFDA Data

SPL SET ID:b033c169-4943-4ad9-ace0-7e4a1f0dc100
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310433
  • 310434

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

    NDCBrand NameGeneric Name
    0093-4443GabapentinGabapentin
    0093-4444GabapentinGabapentin
    0143-3991GabapentinGabapentin
    0143-3993GabapentinGabapentin
    0143-3994GabapentinGabapentin
    0143-9992GabapentinGabapentin
    0143-9993GabapentinGabapentin
    0143-9994GabapentinGabapentin
    67877-222GabapentinGabapentin
    67877-223GabapentinGabapentin
    67877-224GabapentinGabapentin
    67877-428GabapentinGabapentin
    67877-429GabapentinGabapentin
    68001-006GabapentinGabapentin
    68001-007GabapentinGabapentin
    68071-1212GABAPENTINGABAPENTIN
    68071-1292GabapentinGabapentin
    68071-1808GABAPENTINGABAPENTIN
    68071-1907GABAPENTINGABAPENTIN
    68071-1995GabapentinGabapentin
    68071-3230GABAPENTINGABAPENTIN
    68071-3046GabapentinGabapentin
    68071-3244GabapentinGabapentin
    68071-4087GabapentinGabapentin
    68071-3086GABAPENTINGABAPENTIN
    68071-3383GABAPENTINGABAPENTIN
    68071-3314GABAPENTINGABAPENTIN
    68071-4049GABAPENTINGABAPENTIN
    68071-4241GABAPENTINGABAPENTIN
    68071-4099GabapentinGabapentin
    68071-4113GabapentinGabapentin
    68071-4292GabapentinGabapentin
    68071-4180GabapentinGabapentin
    68071-4090GabapentinGabapentin
    68071-4329GabapentinGabapentin
    68071-4603GabapentinGabapentin
    68071-4169GabapentinGabapentin
    68071-4346GabapentinGabapentin
    68071-4366GabapentinGabapentin
    68071-4729GabapentinGabapentin
    68071-4402GABAPENTINGABAPENTIN
    68071-4784GABAPENTINGABAPENTIN
    68084-774GabapentinGabapentin
    68084-783GabapentinGabapentin
    68084-797GabapentinGabapentin
    68084-762GabapentinGabapentin
    0440-5562GABAPENTINGABAPENTIN
    0440-5563GABAPENTINGABAPENTIN
    68084-802GabapentinGabapentin
    68151-1028GabapentinGabapentin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.